Global Demineralized Bone Matrix (DBM) Revenue Is Nearly 620 M USD In 2017
Warning: date() expects parameter 2 to be long, string given in /www/wwwroot/www.globalinforesearch.com/static/themes/default/info_detail.php on line 32
In the last several years, global market of demineralized bone matrix (DBM) developed rapidly, with an average growth rate of 9.48%. In 2017, global revenue of demineralized bone matrix (DBM) is nearly 620 M USD; the actual consumption is about 18.6 million units.
The classification of demineralized bone matrix (DBM) includes gel, putty, putty with chips, and the proportion of Putty in 2017 is about 46%, and the proportion is in decreasing trend from 2013 to 2017.
Demineralized bone matrix (DBM) is widely used in dental surgery, spine surgery, trauma surgery. The most proportion of demineralized bone matrix (DBM) is for spine surgery, and the proportion in 2017 is about 78%.
North America is the largest consumption place, with a consumption market share nearly 56% in 2017. Following North America, Europe is the second largest consumption place with the consumption market share of 30%.
Market competition is intense. Medtronic, J &J (DePuy Synthes), Zimmer Biomet, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.